Evidence map›Paper›PMID 37842297›Full record

ArticleFrontiers in endocrinology2023

Pre-pregnancy body mass index and glycated-hemoglobin with the risk of metabolic diseases in gestational diabetes: a prospective cohort study.

Xinyue Wang, Simin Zhang, Wenlu Yu, Guohua Li, Jinglin Li, Jing Ji, Yang Mi, Xiaoqin Luo

Open access · goldAbstract read
In one paragraph

Article in Frontiers in endocrinology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Research Progress of Risk Factors Associated with Gestational Diabetes Mellitus.Endocrine, metabolic & immune disorders drug targets · 2025
    Review
  5. Article
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Xinyue WangDepartment of Nutrition and Food Safety, School of Public Health, Xi'an Jiaotong University, Xi'an, China.
Simin ZhangDepartment of Nutrition and Food Safety, School of Public Health, Xi'an Jiaotong University, Xi'an, China.
Wenlu YuDepartment of Nutrition and Food Safety, School of Public Health, Xi'an Jiaotong University, Xi'an, China.
Guohua LiDepartment of Nutrition and Food Safety, School of Public Health, Xi'an Jiaotong University, Xi'an, China.
Jinglin LiDepartment of Nutrition and Food Safety, School of Public Health, Xi'an Jiaotong University, Xi'an, China.
Jing JiDepartment of Nutrition and Food Safety, School of Public Health, Xi'an Jiaotong University, Xi'an, China.
Yang MiDepartment of Obstetrics and Gynecology, Northwest Women's and Children's Hospital, Xi'an, China.
Xiaoqin LuoDepartment of Nutrition and Food Safety, School of Public Health, Xi'an Jiaotong University, Xi'an, China.
Xi'an Jiaotong University · CNNorthwest Women's and Children's Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Metabolic diseases during pregnancy result in negative consequences for mothers. Pre-pregnancy body mass index (BMI) and late-pregnancy glycated-hemoglobin (HbA1c) are most important factors independently affecting the risk of gestational diabetes mellitus (GDM). However how both affect the combined risk of other metabolic diseases in women with GDM is unclear. The study aims to investigate the influence of pre-pregnancy BMI and pregnancy glycemic levels on other gestational metabolic diseases in women with GDM. Methods: Pregnancies with GDM from January 2015 to December 2018 in the Xi'an longitudinal mother-child cohort study (XAMC) were retrospectively enrolled. Those without other metabolic diseases by the time of oral glucose tolerance test (OGTT) detection were finally recruited and divided into four groups by pre-pregnancy BMI (Underweight <18.5kg/m Results: A total of 8928 subjects with GDM were included, 16.2% of which had a composite of metabolic diseases. The pre-pregnancy overweight and obesity, compared with normal BMI, were linked to the elevated risk of the composite of metabolic diseases, particularly pre-eclampsia (both Conclusion: Pre-pregnancy overweight/obesity and late-pregnancy high HbA1c increased the risk of other gestational metabolic diseases of women with GDM. Monitoring and controlling late-pregnancy HbA1c was effective in reducing metabolic diseases, particularly in those who were overweight/obese before conception.

Indexed as

Diabetes, GestationalHypertension, Pregnancy-InducedPre-EclampsiaBody Mass IndexCohort StudiesFemaleGlycated HemoglobinHumansObesityOverweightPregnancyPregnancy OutcomeProspective StudiesRetrospective StudiesGlycated Hemoglobingestational diabetes mellitusgestational hypertensiongestational metabolic diseaseshigh glycated hemoglobinpre-pregnancy body mass index

Identifiers

PMID37842297
PMCPMC10569468
OpenAlexW4387181732

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.